Effects and mechanism of miR-214 on hepatocellular carcinoma

Asian Pacific Journal of Tropical Medicine

Volumn 8, Issue 5, 2015, Pages 392-398

  Zhang, Li Li ^a   Guo, Yan Jun ^a   Zhao, Chun Na ^a   Gao, Jian Yun ^a  

^a Department of Gastroenterology Qiqihaer Medical College Affiliated training hospital Daqing Oil Field General Hospital   (China)

Author keywords

Hepatocellular carcinoma; MiR 214; catenin pathway

Indexed keywords

BETA CATENIN; CYCLIN D; MICRORNA 214; MYC PROTEIN; TRANSCRIPTION FACTOR 7;

ARTICLE; BETA CATENIN GENE; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMING UNIT; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HEPG2 CELL LINE; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84930249731     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(14)60350-3     Document Type: Article

References (32)

1. Giordano S, Columbano A MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?. Hepatology 2013, 57(2):840-847.
2. Rossi L, Zoratto F, Papa A, Iodice F, Minozzi M, Frati L, et al. Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2010, 2(9):348-359.
3. Babashah S, Soleimani M The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 2011, 47(8):1127-1137.
4. Xia H, Ooi LLPJ, Hui KM MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma. PLoS One 2012, 7(9):e44206.
5. Karakatsanis A, Papaconstantinou I, Gazouli M, Lyberopoulou A, Polymeneas G, Voros D Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance. Mol Carcinog 2013, 52(4):297-303.
6. Sonia AM, Manel E Dysregulation of microRNAs in cancer: Playing with fire. Epigenetics 2011, 585(13):2087-2099.
7. Croce CM Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genetics 2009, 10(10):704-714.
8. Duan Q, Wang X, Gong W, Ni L, Chen C, He X, et al. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One 2012, 7(2):e31518.
9. Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, et al. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. J Hepatol 2012, 57(3):584-591.
10. Kong YW, Ferland-McCollough D, Jackson TJ, Bushell M microRNAs in cancer management. Lancet Oncol 2012, 13(6):249-258.
11. Pereira DM, Rodrigues PM, Borralho PM, Rodrigues CM Delivering the promise of miRNA cancer therapeutics. Drug Discov Today 2013, 18(5):282-289.
12. Yang TS, Yang XH, Wang XD, Wang YL, Zhou B, Song ZS MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int 2013, 13(1):68.
13. Wang F, Liu M, Li X, Tang H MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells. FEBS Lett 2013, 587(5):488-495.
14. Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, Zeng MS, et al. Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. PloS One 2014, 9(1):e86149.
15. 1 phase by directly targeting CCNE1 in human hepatocellular carcinoma cells. Biochem Biophys Res Commun 2014, 443(3):1078-1084.
16. Feng R, Chen X, Yu Y, Su L, Yu B, Li J, et al. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett 2010, 298(1):50-63.
17. Zhang XJ, Ye H, Zeng CW, He B, Zhang H, Chen YQ Dysregulation of miR-15a and miR-214 in human pancreatic cancer. J Hematol Oncol 2010, 3(1):46.
18. Li B, Han Q, Zhu Y, Yu Y, Wang J, Jiang X Down-regulation of miR-214 contributes to intrahepatic cholangiocarcinoma metastasis by targeting Twist. FEBS J 2012, 279(13):2393-2398.
19. Chou J, Werb Z MicroRNAs play a big role in regulating ovarian cancer-associated fibroblasts and the tumor microenvironment. Cancer Discov 2012, 2(12):1078-1080.
20. Liu Z, Tu K, Liu Q Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma. FEBS Lett 2014, 588(17):3089-3097.
21. Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011, 55(6):1339-1345.
22. Borel F, Konstantinova P, Jansen PLM Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J Hepatol 2012, 56(6):1371-1383.
23. Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, Minguez B, et al. MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a. Gastroenterology 2011, 2011:1618-1628.
24. Yu L, Zhang J, Guo X, Li Z, Zhang P MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma. Cancer Epidemiol 2014, 33(4):408-413.
25. Gaujoux S, Hantel C, Launay P, Bonnet S, Perlemoine K, Lefèvre L, et al. Silencing mutated β-catenin inhibits cell proliferation and stimulates apoptosis in the adrenocortical cancer cell line H295R. PloS One 2013, 8(2):e55743.
26. Morikawa T, Kuchiba A, Lochhead P, Bonnet S, Perlemoine K, Lefèvre L, et al. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status. Cancer Res 2013, 73(5):1600-1610.
27. White BD, Chien AJ, Dawson DW Dysregulation of Wnt/β-catenin signaling in gastrointestinal cancers. Gastroenterology 2012, 142(2):219-232.
28. Tsao CM, Yan MD, Shih YL, Yu PN, Kuo CC, Lin WC, et al. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma. Hepatology 2012, 56(6):2277-2287.
29. Mathew S, Ali A, Abdel-Hafiz H, Fatima K, Suhail M, Archunan G, et al. Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infect Genet Evol 2014, 26:327-339.
30. Pez F, Lopez A, Kim M, Wands JR, de Fromentel CC, Merle P Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol 2013, 59(5):1107-1117.
31. Misiewicz-Krzeminska I, Sarasquete ME, Quwaider D, Krzeminski P, Ticona FV, Paíno T, et al. Restoration of miR-214 expression reduces growth of myeloma cells through a positive regulation of P53 and inhibition of DNA replication. Haematologica 2012, 2012:070011.
32. Xu Z, Wang T miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1. Biochem Biophys Res Commun 2014, 449(2):190-195.